Biologics - Resources

Explore our brands

Our brands bring together the industry's most influential leaders and scientific experts, inspiring thought-provoking and insightful content that offers a unique perspective on R&D trends and challenges.

14/05/24 - Epstein-Barr virus has been highly linked to over ten forms of cancer. This wide range of malignant implications means an expanded variety of target indications for the vaccine.

Explore our brands

Content Type

Subjects

Keywords

Peptides

Insulin: Recombinant Production, Sustainability, and Chemistry

Novo Nordisk has implemented recombinant peptide production techniques with chemical and enzymatic transformations to reduce its carbon footprint in insulin production, as explained by Thomas Høeg-Jensen, Scientific Director at Novo Nordisk.

Vaccines

World Malaria Day 2023: Breakthroughs in Malaria Vaccinations

April 25th marks World Malaria Day, an opportunity to raise awareness about the disease’s impact and efforts to control and prevent it.

Proteins & Antibodies

App Note: CAR-T: A Promising Cell Therapy for Cancer Treatment

This application note by Sino Biological explores the key steps involved in CAR-T production to provide insights into the challenges that may impede successful CAR-T therapy.

Bispecifics

The Bispecific Antibody Landscape

Key opinion leaders explore recent developments for bispecific antibodies, from new delivery technologies to the complexity of their pharmacokinetic profiles.

Proteins & Antibodies

Tiny but Mighty Molecular Syringe Developed Using AI

An AI-modified molecular “syringe” harnessed from bacteria could revolutionise protein delivery for gene and cancer therapies.

Vaccines

In Vivo Model Design and Assay Selection to Aid in Progression from Preclinical to Clinical

Nexelis discussed the preclinical stage of vaccine development at Vaccines EU 2022, highlighting that the choices made during this stage will impact the rest of the development process.